Join
Live feed
·
INSIDERFilingvia Quantisnow
Aktis Oncology Inc. logo

Boller Kenneth bought $30,000 worth of shares (60,000 units at $0.50), increasing direct ownership by 39% to 214,957 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AKTS (Aktis Oncology Inc.) and more on Quantisnow.

Boller Kenneth bought $30,000 worth of shares (60,000 units at $0.50), increasing direct ownership by 39% to 214,957 units (SEC Form 4) | Quantisnow